OSRH Q3 2025 Earnings — OSR Holdings, Inc. Revenue & Financial Results | Market Cap Arena

OSRHOSR Holdings, Inc.

$13M

Q3 2025 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$627,747

Gross Profit

$261,73441.7% margin

Operating Income

-$4M-605.9% margin

Net Income

-$2M-338.8% margin

EPS (Diluted)

$-0.71

QoQ Revenue Growth

-44.7%

Cash Flow

Operating Cash Flow

-$3M

Free Cash Flow

-$3M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$177M

Total Liabilities

$43M

Stockholders' Equity

$82M

Cash & Equivalents

$2M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$627,747	$0	—
Gross Profit	$261,734	$0	—
Operating Income	-$4M	-$454,000	-737.8%
Net Income	-$2M	-$231,000	-820.6%